As regulations surrounding inhalation device sustainability evolve, we help you streamline the process of transitioning to low global warming potential (GWP) propellants. Clinical supply for green propellants HFA152a and HFO1234ze is already available, with commercial scale available this year and plans for further expansion.
Download this information sheet to dive deeper into our low-GWP propellant expertise, including:
- An overview of our legacy of respiratory drug delivery innovations
- Invention of the first pressurized metered-dose inhaler (pMDI)
- Transition to CFC-free pMDIs
- Proven track record in generics
- How this experience makes us a leading CDMO partner for green propellants
- Why now is the time to start transitioning your products